Xellsmart Bio-pharmaceutical (suzhou) Co., Ltd.

This study tests a single injection of lab-grown nerve cells made from stem cells to treat early-onset Parkinson's disease. The cells are designed to replace the dopamine-producing neurons that are lost in Parkinson's. The trial has two phases: first, a small safety test in 6-12 …

This early-stage study tests a new treatment called XS228, made from special stem cells that can become nerve cells. The goal is to see if injecting these cells into the spine is safe and tolerable for people who had a spinal cord injury 2 to 8 weeks ago. Up to 12 adults with inj…

This early-stage trial tests whether injecting lab-grown nerve cells (made from stem cells) into the spinal cord is safe for people with ALS, a fatal disease that destroys movement control. Twelve participants will receive the cells either once or four times over six months. The …

This early-stage trial tests a single injection of lab-grown nerve cells into the brains of 12 people with Parkinson's disease. The cells are made from stem cells and designed to replace dopamine-producing neurons. The main goal is to check safety and tolerability over 28 days, n…